Saurabh Mittal, Managing Director & CEO of Greenlam Industries expects a strong recovery in 2025-26 (FY26), with growth ...

Microsoft's FY25 Q2 earnings reveal a decline in Xbox hardware revenue, while content and services revenue has increased. The ...

As part of the corporate action, the micro cap company said it will issue 15,87,30,000 equity shares. It further added that ...

India's second largest state-run lender by assets, aims to recover bad loans worth 170 billion rupees ($1.96 billion) this ...

Apparel exports contributed $23.55 billion during the first half (July-January) of FY25, indicating a 12% increase compared ...

Excerpt: BSE-listed SmallCap company, Man Infra, has declared an interim dividend of 22.5 per cent for the financial year ...

Country's export earnings witnessed a 11.68 percent growth year-on-year in the seven months of the current fiscal year ...

PointsBet announced its Q2 FY25 results, with a total net win of $69.9 million, unchanged from the same time last year.

MedPlus Health Services is prioritizing private label growth, as a 1% increase in sales from this segment raises overall margins by 0.4% to 0.5%.

Research is projecting a 5% net profit growth rate for Bursa Malaysia in financial year 2025 (FY25) driven by average daily ...

Alembic Pharmaceuticals tumbled 3.43% to Rs 905 after the company's consolidated net profit tumbled 23.29% to Rs 138.42 crore in Q3 FY25, compared with Rs 180.45 crore posted in Q3 FY24.

NSE/BSE: CUBEINVIT/543899], managed by Cube Highways Fund Advisors Pvt. Ltd. (the "Investment Manager"), has announced its ...